<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04852744</url>
  </required_header>
  <id_info>
    <org_study_id>2019-A00366-51</org_study_id>
    <nct_id>NCT04852744</nct_id>
  </id_info>
  <brief_title>NEUROIMAGING OF ADOLESCENT BORDERLINE PERSONALITY DISORDER WITH AND WITHOUT POST-TRAUMATIC STRESS DISORDER</brief_title>
  <acronym>BorderStress</acronym>
  <official_title>NEUROIMAGERIE DU TROUBLE DE LA PERSONNALITE BORDERLINE A L'ADOLESCENCE AVEC ET SANS TROUBLE DE STRESS POST-TRAUMATIQUE</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Caen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>CHU de Rouen - Accueil</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centre Hospitalier Universitaire de Caen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Université de Caen Normandie</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centre Hospitalier du Rouvray</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Groupe Hospitalier du Havre</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Caen</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Borderline personality disorder (BPD) is a common mental disorder in adolescents with&#xD;
      significant individual and societal repercussions, characterized over the long term by&#xD;
      emotional hyperresponsiveness, relational instability, identity disturbances and&#xD;
      self-aggressive behavior. The etiology of BPD is multifactorial and involves exposure to&#xD;
      traumatic life events, which are present in the majority of cases. This explains the very&#xD;
      common co-morbidity between BPD and post-traumatic stress disorder (PTSD), which involves&#xD;
      emotionally painful memory relapses of one or more traumatic events, associated with an&#xD;
      emotional trauma avoidance syndrome (s). ) and hypervigilance. Brain imaging studies in&#xD;
      adolescents with BPD have shown decreases in the volume of gray matter within the&#xD;
      frontolimbic network, as well as a decrease in frontolimbic white matter bundles. These brain&#xD;
      changes are considered to be biological markers of TPB. However, the exact same brain changes&#xD;
      are seen in PTSD. Although it represents more than a third of adolescents hospitalized in&#xD;
      psychiatry, neuroscientific studies of BPD in adolescence are still scarce. The expertise we&#xD;
      have acquired in U1077 in adolescents with PTSD offers us an exceptional opportunity to&#xD;
      characterize in BPD with and without PTSD structural anomalies, including the hippocampus,&#xD;
      and functional at rest, never used for hour in the teenager's BPD. Beyond that, carrying out&#xD;
      an 18-month follow-up of the patients will allow us to assess the predictive value of these&#xD;
      anomalies on the level of general psychopathology in all the patients studied and the&#xD;
      intensity of the symptoms of traumatic relapse in the patients with PTSD. This modeling of&#xD;
      disorders integrating psychopathological, neuropsychological and neuroanatomical approaches&#xD;
      will provide the clinician with new knowledge necessary for therapeutic innovation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A - RESEARCH OBJECTIVES&#xD;
&#xD;
        1. Primary objective:&#xD;
&#xD;
           • Compare the hippocampal volume between adolescent girls with BPD with and without PTSD&#xD;
&#xD;
        2. Secondary objectives:&#xD;
&#xD;
             -  1 - Evaluate the link, transverse and long-term (18 months), between the&#xD;
                hippocampal volume and the level of general psychopathology in all the patients&#xD;
                studied, and between the hippocampal volume and the intensity of the symptoms of&#xD;
                traumatic revival in adolescent girls with PTSD.&#xD;
&#xD;
             -  2 - Compare the volume of the hippocampal subfields between adolescent girls with&#xD;
                BPD with and without PTSD, and assess in patients with PTSD the link, transverse&#xD;
                and long-term (18 months), between volumes of the hippocampal sub-fields and&#xD;
                intensity symptoms of traumatic revival&#xD;
&#xD;
             -  3 - Compare the volume and integrity of the white matter bundles of the&#xD;
                fronto-limbic network between adolescent girls with BPD with and without PTSD&#xD;
&#xD;
             -  4 - Compare resting brain activity between adolescent girls with BPD with and&#xD;
                without PTSD&#xD;
&#xD;
             -  5 - Explore the links between changes in the brain and the intensity of the main&#xD;
                psychological alterations associated with BPD in adolescence: i) attachment&#xD;
                insecurity; ii) emotional dysregulation; iii) attention deficit and dysexecutive&#xD;
                syndrome; iv) hypermentalization; and v) autobiographical memory and dissemination&#xD;
                of identity.&#xD;
&#xD;
      B - Secondary evaluation criteria:&#xD;
&#xD;
        -  1 - Hippocampal volume (VBM); Global Clinical Assessment Scale score (CGA-S; Endicott et&#xD;
           al., 1976); &quot;Réviviscences&quot; score in the French version of the UCLA Post-Traumatic&#xD;
           Stress Disorder Reaction Index for Children and Adolescents (UCLA PTSD-RI C / A;&#xD;
           Steinberg et al., 2013).&#xD;
&#xD;
        -  2 - Volume of each hippocampal subfield (Ammon's Horn [CA] 1, CA2, CA3, dentate gyrus,&#xD;
           subiculum: anatomical MRI; Region Of Interest [ROI] method; Postel et al., 2019);&#xD;
           &quot;Intrusion&quot; score of the French version of the UCLA PTSD-RI C / A.&#xD;
&#xD;
        -  3 - Orbitofrontal and cingulate cortex volume (VBM); anisotropy fraction (fractional&#xD;
           anisotropy; FA) and average diffusivity (apparent diffusion coefficient; ADC) of&#xD;
           fronto-limbic white matter beams (IRM Diffusion Tensor Imaging [DTI]; Le Bihan et al.,&#xD;
           2001).&#xD;
&#xD;
        -  4 - Functional connectivity of brain networks in the resting state: default network&#xD;
           (default mode network), salience network and central executive network; Viard et al.,&#xD;
           2019).&#xD;
&#xD;
        -  5 - Brain modifications (VBM, ROI, AF, ADC, functional connectivity of resting networks)&#xD;
           and: i) &quot;Insecure attachment&quot; score to Individual Relationship Model Cards (Ca-MIR;&#xD;
           Pierrehumbert et al., 1996); ii) score &quot;Separation-distress&quot; and &quot;Fear&quot; in the French&#xD;
           version of the Affective Neuroscience Personality Scale (ANPS; Pahlavan et al., 2008);&#xD;
           iii) Continuous Performance Test omission score (CPT; Conners, 2002) and Wisconsin Card&#xD;
           Sorting Test perseverance score (WCST; Heaton et al., 1993); iv) &quot;Hypermentalisation&quot;&#xD;
           score in the French version of the Movie Assessment of Social Cognition (MASC; Martinez&#xD;
           et al., 2017) and of the Reflective Functioning Questionnaire (RFQ; Badoud et al.,&#xD;
           2015); and v) measurement of the quality of autobiographical productions (Reese et al.,&#xD;
           2011), total score in the French version of the Assessment of Identity Development in&#xD;
           Adolescence (AIDA; Goth et al., 2012).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2021</start_date>
  <completion_date type="Anticipated">June 1, 2024</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hippocampal volume</measure>
    <time_frame>during the month following inclusion</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">99</enrollment>
  <condition>Borderline Personality Disorder</condition>
  <arm_group>
    <arm_group_label>Borderline girls with PTSD</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>female&#xD;
Age between 13 and 17 years inclusive&#xD;
Diagnosis of borderline personality disorder according to the criteria of the Diagnostic and Statistical Manual for mental disorders, fifth edition (DSM-5; American Psychiatric Association, 2013; SIDP-IV)&#xD;
Post-traumatic stress disorder according to DSM-5 criteria (American Psychiatric Association, 2013; K-SADS-PL)&#xD;
Level of general psychopathology compatible with participation in the study (score&gt; 20 on the CGA-S)&#xD;
Oral and written comprehension of the French language&#xD;
Affiliation to the social security scheme&#xD;
Informed consent signed by the legal representatives holding the exercise of parental authority and the adolescent herself</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Borderline girls without PTSD</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>female&#xD;
Age between 13 and 17 years inclusive&#xD;
Diagnosis of borderline personality disorder according to the criteria of the Diagnostic and Statistical Manual for mental disorders, fifth edition (DSM-5; American Psychiatric Association, 2013; SIDP-IV)&#xD;
Level of general psychopathology compatible with participation in the study (score&gt; 20 on the CGA-S)&#xD;
Oral and written comprehension of the French language&#xD;
Affiliation to the social security scheme&#xD;
Informed consent signed by the legal representatives holding the exercise of parental authority and the adolescent herself</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy controls</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>female&#xD;
Age between 13 and 17 years inclusive&#xD;
Absence of mental disorder according to DSM-5 (American Psychiatric Association, 2013 ; K-SADS-PL et SIDP-IV)&#xD;
Oral and written comprehension of the French language&#xD;
Affiliation to the social security scheme&#xD;
Informed consent signed by the legal representatives holding the exercise of parental authority and the adolescent herself</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Brain MRI</intervention_name>
    <description>Anatomical MRI The anatomical data will be acquired by means of a 3T Signa Premier General Electric Healthcare MRI, allowing the acquisition of classic anatomical sequences (T1, T2) and a high-resolution hippocampal sequence allowing to accurately apprehend its various sub-fields. (total acquisition time: 10 min).&#xD;
The hippocampal volume, the orbital-frontal cortex and the cingulate cortex will be measured by voxel-based morphometry (VBM; Ashburner &amp; Friston, 2000]) using the SPM software (Statistical Parametric Mapping; Friston et al., 2006). The voxel-by-voxel morphometric analysis of T1 MRI images makes it possible to classify and segment the different brain tissues (gray matter versus white matter) and to analyze the focal differences in volume within these tissues between the different groups.</description>
    <arm_group_label>Borderline girls with PTSD</arm_group_label>
    <arm_group_label>Borderline girls without PTSD</arm_group_label>
    <arm_group_label>Healthy controls</arm_group_label>
    <other_name>Psychological and behavioural assessment</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        For the 3 groups:&#xD;
&#xD;
          -  female&#xD;
&#xD;
          -  Age between 13 and 17 years inclusive&#xD;
&#xD;
          -  Oral and written comprehension of the French language&#xD;
&#xD;
          -  Affiliation to the social security scheme&#xD;
&#xD;
          -  Informed consent signed by the legal representatives holding the exercise of parental&#xD;
             authority and the adolescent herself&#xD;
&#xD;
        For patients:&#xD;
&#xD;
          -  Diagnosis of borderline personality disorder according to the criteria of the&#xD;
             Diagnostic and Statistical Manual for mental disorders, fifth edition (DSM-5; American&#xD;
             Psychiatric Association, 2013; SIDP-IV)&#xD;
&#xD;
          -  Level of general psychopathology compatible with participation in the study (score&gt; 20&#xD;
             on the CGA-S)&#xD;
&#xD;
        TB + / PTSD + group:&#xD;
&#xD;
        - Post-traumatic stress disorder according to DSM-5 criteria (American Psychiatric&#xD;
        Association, 2013; K-SADS-PL)&#xD;
&#xD;
        In the control group :&#xD;
&#xD;
          -  Absence of mental disorder according to DSM-5 criteria (American Psychiatric&#xD;
             Association, 2013; K-SADS-PL and SIDP-IV)&#xD;
&#xD;
          -  Oral and written comprehension of the French language&#xD;
&#xD;
          -  Informed consent signed by the legal representative, the holder (s) of the exercise of&#xD;
             parental authority and the adolescent herself&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  - Illiteracy / illiteracy&#xD;
&#xD;
          -  Sensory disorder (visual, auditory)&#xD;
&#xD;
          -  Severe chronic psychiatric comorbidity: autism spectrum disorder, intellectual&#xD;
             disability, schizophrenia spectrum disorder and other psychotic disorders, bipolar&#xD;
             disorder&#xD;
&#xD;
          -  Severe or current brain pathology (chronic neurological disease, encephalitis, history&#xD;
             of severe head trauma), alertness disorder&#xD;
&#xD;
          -  History of anoxic coma&#xD;
&#xD;
          -  Contraindication to MRI (magnetic foreign body, claustrophobia, contraindication to&#xD;
             prolonged lying down)&#xD;
&#xD;
          -  Severe physical pathology in progress&#xD;
&#xD;
          -  Moving outside the Normandy region planned within 18 months&#xD;
&#xD;
          -  The inclusion of the subject in another biomedical research protocol (during the&#xD;
             present study)&#xD;
&#xD;
          -  Intellectual deficit (IQ &lt;70)&#xD;
&#xD;
          -  Pregnant or breastfeeding women&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Fabian Guénolé, Pr.</last_name>
    <phone>+33 (0) 231 272 309</phone>
    <email>guenole-f@chu-caen.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bérengère Guillery-Girard, Ass.Pr.</last_name>
    <phone>+33 (0) 231 568 399</phone>
    <email>berengere.guillery@unicaen.fr</email>
  </overall_contact_backup>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 16, 2021</study_first_submitted>
  <study_first_submitted_qc>April 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 21, 2021</study_first_posted>
  <last_update_submitted>April 23, 2021</last_update_submitted>
  <last_update_submitted_qc>April 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Adolescence</keyword>
  <keyword>Hippocampus</keyword>
  <keyword>Neuropsychology</keyword>
  <keyword>Borderline personality disorder</keyword>
  <keyword>Post-traumatic stress disorder</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Personality Disorders</mesh_term>
    <mesh_term>Borderline Personality Disorder</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

